N-Ethylhexedrone was patented because of the German pharmaceutical organization Boehringer Ingelheim in 1964 as a potential anorexigenic agent. The patent describes its synthesis along with other derivatives of aminoketone.[1]We now have designed a systemic approach that brings together the human networks, procedures and scientific applications ess